BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29100317)

  • 41. Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition.
    Shaban NM; Yan R; Shi K; Moraes SN; Cheng AZ; Carpenter MA; McLellan JS; Yu Z; Harris RS
    Sci Adv; 2022 Apr; 8(17):eabm2827. PubMed ID: 35476445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for APOBEC3B mRNA and protein expression in oral squamous cell carcinomas.
    Fanourakis G; Tosios K; Papanikolaou N; Chatzistamou I; Xydous M; Tseleni-Balafouta S; Sklavounou A; Voutsinas GE; Vastardis H
    Exp Mol Pathol; 2016 Dec; 101(3):314-319. PubMed ID: 27818121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes.
    del Valle J; Feliubadaló L; Nadal M; Teulé A; Miró R; Cuesta R; Tornero E; Menéndez M; Darder E; Brunet J; Capellà G; Blanco I; Lázaro C
    Breast Cancer Res Treat; 2010 Aug; 122(3):733-43. PubMed ID: 19894111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
    Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
    Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of point mutations and large rearrangements in the BRCA1 gene in 667 Turkish unselected ovarian cancer patients.
    Aktas D; Gultekin M; Kabacam S; Alikasifoglu M; Turan AT; Tulunay G; Kose MF; Ortac F; Yüce K; Tunçbilek E; Ayhan A
    Gynecol Oncol; 2010 Oct; 119(1):131-5. PubMed ID: 20638108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The roles of APOBEC3B in gastric cancer.
    Zhang J; Wei W; Jin HC; Ying RC; Zhu AK; Zhang FJ
    Int J Clin Exp Pathol; 2015; 8(5):5089-96. PubMed ID: 26191203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].
    Li H; Ding J; Wang W; Chen Y; Lu W; Shao H; Wu BL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):318-22. PubMed ID: 19504448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
    Knappskog S; Geisler J; Arnesen T; Lillehaug JR; Lønning PE
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1155-63. PubMed ID: 17001621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India.
    Singh H; Marathe SD; Nain S; Nema V; Ghate MV; Gangakhedkar RR
    APMIS; 2016 Oct; 124(10):881-7. PubMed ID: 27522954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large genomic deletions inactivate the BRCA2 gene in breast cancer families.
    Agata S; Dalla Palma M; Callegaro M; Scaini MC; Menin C; Ghiotto C; Nicoletto O; Zavagno G; Chieco-Bianchi L; D'Andrea E; Montagna M
    J Med Genet; 2005 Oct; 42(10):e64. PubMed ID: 16199546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a novel large deletion in a patient with severe factor V deficiency using an in-house F5 MLPA assay.
    Nuzzo F; Paraboschi EM; Straniero L; Pavlova A; Duga S; Castoldi E
    Haemophilia; 2015 Jan; 21(1):140-7. PubMed ID: 25438872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: evidence for both homologous and non-homologous mechanisms of rearrangement.
    Kozak L; Hrabincova E; Kintr J; Horky O; Zapletalova P; Blahakova I; Mejstrik P; Prochazkova D
    Mol Genet Metab; 2006 Dec; 89(4):300-9. PubMed ID: 16931086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
    Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
    J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
    Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolvability of cancer-associated genes under APOBEC3A/B selection.
    Song JH; Dávalos LM; MacCarthy T; Damaghi M
    iScience; 2024 Apr; 27(4):109433. PubMed ID: 38550998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APOBEC3 Deletion is Associated with Breast Cancer Risk in a Sample of Southeast Iranian Population.
    Rezaei M; Hashemi M; Hashemi SM; Mashhadi MA; Taheri M
    Int J Mol Cell Med; 2015; 4(2):103-8. PubMed ID: 26261799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.